Cargando…
Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, in which prognosis is determined by liver fibrosis. A common variant in hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13, rs72613567-A) is associated with a reduced risk of fibrosis in NAFLD, but the underlying mecha...
Autores principales: | Luukkonen, Panu K., Sakuma, Ikki, Gaspar, Rafael C., Mooring, Meghan, Nasiri, Ali, Kahn, Mario, Zhang, Xian-Man, Zhang, Dongyan, Sammalkorpi, Henna, Penttilä, Anne K., Orho-Melander, Marju, Arola, Johanna, Juuti, Anne, Zhang, Xuchen, Yimlamai, Dean, Yki-Järvinen, Hannele, Petersen, Kitt Falk, Shulman, Gerald I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942818/ https://www.ncbi.nlm.nih.gov/pubmed/36669104 http://dx.doi.org/10.1073/pnas.2217543120 |
Ejemplares similares
-
Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity
por: Lahelma, Mari, et al.
Publicado: (2021) -
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2022) -
Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study
por: Lallukka, Susanna, et al.
Publicado: (2017) -
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021) -
Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling
por: Jian, Ching, et al.
Publicado: (2020)